Brind.

Goldman Sachs expressed bullish sentiment regarding Dexcom, driven by U.S. growth expectations.

1 report, 1 independent Updated Aug 8

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Dexcom Goldman Sachs

Keep exploring

The entities involved

Dexcom
company that develops, manufactures and distributes continuous glucose monitoring systems
- Tandem Mobi utilizes Dexcom G7 technology for monitoring.Mon 09:18
- Oura announces partnerships with Dexcom and Resmed for health feature integration, while noting that regulatory uncertainty affects its product scope.Wed 08:52
Goldman Sachs
American investment bank
- US-Iran truce aims to reopen Strait of Hormuz amid global monetary policy shifts and oil price drops.Mon 17:37
- Goldman Sachs, Morgan Stanley, JPMorgan Chase, and Bank of America are competing in the global investment banking sector.Mon 17:24

Related events

Coverage

Newest first; wire copies grouped

Aug 8BenzingaInsulet Peer Tandem Diabetes Underwhelming Earnings, Dull Outlook Drags Stock Tandem Diabetes Care Inc.’s (NASDAQ:TNDM) stock plunged on Thursday after the company cut its annual guidance. The diabet